ReShape Lifesciences Inc.
RSLS
Price:
$6.1056
Market Cap:
$3.09M
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion...[Read more]
Industry
Medical - Devices
IPO Date
2016-10-06
Stock Exchange
NASDAQ
Ticker
RSLS
PE Ratio
[0.26]
ROE
[-208.37%]
Current Ratio
[1.90]
Dividend Yield
[0%]
Enterprise Value
[2.16M]
Dividend History
The ROE as of November 2024 (TTM) for ReShape Lifesciences Inc. (RSLS) is -208.37%
According to ReShape Lifesciences Inc.’s latest financial reports and current stock price. The company's current ROE is -208.37%. This represents a change of 245.80% compared to the average of -60.26% of the last 4 quarters.
ReShape Lifesciences Inc. (RSLS) Historical ROE (quarterly & annually)
How has RSLS ROE performed in the past?
The mean historical ROE of ReShape Lifesciences Inc. over the last ten years is -420.66%. The current -208.37% ROE has changed -50.46% with respect to the historical average. Over the past ten years (40 quarters), RSLS's ROE was at its highest in in the March 2016 quarter at 588.33%. The ROE was at its lowest in in the September 2016 quarter at -564.72%.
Average
-420.66%
Median
-282.07%
Minimum
-1262.33%
Maximum
-44.28%
ReShape Lifesciences Inc. (RSLS) ROE by Quarter and Year
Discovering the peaks and valleys of ReShape Lifesciences Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 839.05%
Maximum Annual ROE = -44.28%
Minimum Annual Increase = -94.43%
Minimum Annual ROE = -1262.33%
| Year | ROE | Change |
|---|---|---|
| 2023 | -170.90% | -86.46% |
| 2022 | -1262.33% | 839.05% |
| 2021 | -134.43% | -9.96% |
| 2020 | -149.30% | -51.50% |
| 2019 | -307.84% | 20.11% |
| 2018 | -256.30% | 478.78% |
| 2017 | -44.28% | -94.43% |
| 2016 | -794.86% | 14.50% |
| 2015 | -694.23% | 77.06% |
| 2014 | -392.09% | 123.25% |
ReShape Lifesciences Inc. (RSLS) Average ROE
How has RSLS ROE performed in the past?
The current ROE of ReShape Lifesciences Inc. (RSLS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-522.55%
5-year avg
-404.96%
10-year avg
-420.66%
ReShape Lifesciences Inc. (RSLS) ROE vs. Peers
How is RSLS’s ROE compared to its peers?
ReShape Lifesciences Inc.’s ROE is greater than Sintx Technologies, Inc. (-89.99%), greater than Bone Biologics Corporation (-154.16%), greater than Ra Medical Systems, Inc. (-347.48%), greater than Tivic Health Systems, Inc. (-172.08%), greater than Nuwellis, Inc. (-1671.56%), greater than Talis Biomedical Corporation (-79.73%), greater than Tenon Medical, Inc. (-715.68%), greater than INVO Bioscience, Inc. (-1073.76%), greater than Helius Medical Technologies, Inc. (-258.06%), greater than Heart Test Laboratories, Inc. (-144.10%), greater than NeuroMetrix, Inc. (-41.73%), greater than Inspira Technologies Oxy B.H.N. Ltd. (-134.16%), less than OpGen, Inc. (285.24%),
| Company | ROE | Market cap |
|---|---|---|
| -89.99% | $2.31M | |
| -154.16% | $2.73M | |
| -347.48% | $3.84M | |
| -172.08% | $1.79M | |
| -1671.56% | $5.03M | |
| -79.73% | $3.14M | |
| -715.68% | $1.79M | |
| -1073.76% | $3.25M | |
| -258.06% | $1.80M | |
| -144.10% | $2.49M | |
| -41.73% | $7.61M | |
| -134.16% | $23.50M | |
| 285.24% | $14.62M |
Build a custom stock screener for ReShape Lifesciences Inc. (RSLS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ReShape Lifesciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
ReShape Lifesciences Inc. (RSLS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like ReShape Lifesciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is ReShape Lifesciences Inc.'s ROE?
How is the ROE calculated for ReShape Lifesciences Inc. (RSLS)?
What is the highest ROE for ReShape Lifesciences Inc. (RSLS)?
What is the 3-year average ROE for ReShape Lifesciences Inc. (RSLS)?
What is the 5-year average ROE for ReShape Lifesciences Inc. (RSLS)?
How does the current ROE for ReShape Lifesciences Inc. (RSLS) compare to its historical average?